First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
MELBOURNE,Australia,Nov. 28,2024--Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) and Grand Pharmaceutical Group Limited (00512.HK,Grand Pharma) today announce that afirst pat